ignacio catalan (@ign76) 's Twitter Profile
ignacio catalan

@ign76

MD, PhD. Gastroenterology and IBD. Norwegian University of Science, NTNU. #ECCO News Associate Editor. #UEG Education Committee Board. Keen on original ideas!💡

ID: 217700101

calendar_today20-11-2010 07:55:02

3,3K Tweet

2,2K Followers

983 Following

Elliot Tapper (@ebtapper) 's Twitter Profile Photo

1/ WHERE does ascites come from? HOW do diuretics treat ascites? ARE you ready for a #tweetorial? #livertwitter #medtwitter #MedEd

1/

WHERE does ascites come from?
HOW do diuretics treat ascites?
ARE you ready for a #tweetorial?

#livertwitter #medtwitter #MedEd
ignacio catalan (@ign76) 's Twitter Profile Photo

UEG Summer School 2025 my_UEG 🔵 168 participants (360 applications) 🔵 40 Nationalities; 3 from LATAM! 🌍 🔵 48 Faculty (16 EU countries) 🇪🇺 Very happy to help make the best F2F event of the year happen again in beautiful Prague 🏰 Thanks everyone!!! Lots of fun🕺🏿

UEG Summer School 2025 <a href="/my_ueg/">my_UEG</a> 

🔵 168 participants (360 applications)

🔵 40 Nationalities; 3 from LATAM! 🌍

🔵 48 Faculty (16 EU countries) 🇪🇺

Very happy to help make the best F2F event of the year happen again in beautiful Prague 🏰

Thanks everyone!!! Lots of fun🕺🏿
Zlatan Mujagic MD PhD (@mujagiczlatan) 's Twitter Profile Photo

Honored to have participated in this intensive #GI course! Grateful for the opportunity to contribute to the professional development of the next generation of GI specialists. #UEGsummerSchool — highly recommend applying next year!

Seb (@ibdseb) 's Twitter Profile Photo

Reflections from D1 of TOPCLASS #CD fistula consortium meeting ❇️ Huge unmet need in #IBD ❇️Our therapeutic approaches have remained the same (with limited efficacy) for 30 years ❇️Pockets of good practice but we need a global approach ❇️ We can (and are) make progress as

Reflections from D1 of TOPCLASS #CD fistula consortium meeting 
❇️ Huge unmet need in #IBD 
❇️Our therapeutic approaches have remained the same (with limited efficacy) for 30 years 
❇️Pockets of good practice but we need a global approach  
❇️ We can  (and are)  make progress  as
Seb (@ibdseb) 's Twitter Profile Photo

Top 10 priorities in CD-perianal fistula being presented @theoplelly Great to be part of this work from #TOPCLASS consortium supported by James Lind Alliance Now let’s get to solve these challenges 🏃‍♂️ 🏃🏿‍♀️ 🏃🏾

Top 10 priorities in CD-perianal fistula being presented @theoplelly 
Great to be part of this work from #TOPCLASS consortium supported by <a href="/LindAlliance/">James Lind Alliance</a> 
Now let’s get to solve these challenges 🏃‍♂️ 🏃🏿‍♀️ 🏃🏾
Hospital Clínic de València (@gvaclinic) 's Twitter Profile Photo

🆕🏥El Servicio de Medicina Digestiva Hospital Clínic de València celebra la II jornada de Controversias en Enfermedad Inflamatoria Intestinal (EII) con éxito de participación 🔝 👉Lee la noticia completa aquí 🔗breu.gva.es/b/b-z

🆕🏥El Servicio de Medicina Digestiva <a href="/GVAclinic/">Hospital Clínic de València</a> celebra la II jornada de Controversias en Enfermedad Inflamatoria Intestinal (EII) con éxito de participación 🔝

👉Lee la noticia completa aquí 🔗breu.gva.es/b/b-z
Propel a Cure for Crohn’s Disease (@propelacure) 's Twitter Profile Photo

Using AI, University of Alberta researchers analyzed 20 years of data from 30K+ #IBD patients—and found 57% had at least one other related condition, from autoimmune and mental health to heart disease. IBD is systemic. Multidisciplinary care isn’t optional, it’s essential.

Seb (@ibdseb) 's Twitter Profile Photo

Our eagerly awaited #RCT on #JAKis #Upadacitinib in Acute Severe Colitis is now recruiting The ACESO study ACESO ❇️Double blind placebo controlled ❇️ Upfront #upa + IV steroids Vs Iv steroids + Placebo ❇️Option for entry into rescue sub-studies for non responders

Our  eagerly awaited #RCT on #JAKis #Upadacitinib in Acute Severe Colitis is now recruiting 
The ACESO study <a href="/ACESO_ASUC/">ACESO</a>

❇️Double blind placebo controlled 
❇️ Upfront #upa + IV steroids Vs Iv steroids + Placebo 
❇️Option for entry into rescue  sub-studies for non responders
ignacio catalan (@ign76) 's Twitter Profile Photo

Congratulations to Hospital Clínic de València and to the organizers Maia Bosca-Watts and Joan Tosca for a fantastic IBD update course. Thanks for the invitation to address the Prediction of IBD and for the opportunity to meet dear colleagues and friends from Valencia 🇪🇸 Gracias! 🌟

Theo Pelly (@theohpelly) 's Twitter Profile Photo

Presenting the Top 10 Global Research Priorities for Perianal Crohn’s Disease. Shaped by patients, clinicians & researchers worldwide 🌍

Presenting the Top 10 Global Research Priorities for Perianal Crohn’s Disease. Shaped by patients, clinicians &amp; researchers worldwide 🌍
Esteban FV (@efuentesval) 's Twitter Profile Photo

Azathioprine 🆚️ Tofacitinib as Maintenance Therapy in Corticosteroid-Responsive Acute Severe Ulcerative Colitis ▪︎ propensity score–matched, retrospective cohort study ▪︎ Primary endpoint: cumulative event-free survival at 1 year. ▪︎azathioprine 44% 🆚️ tofacitinib 75.%

Azathioprine 🆚️ Tofacitinib as Maintenance Therapy in Corticosteroid-Responsive Acute Severe Ulcerative Colitis

▪︎ propensity score–matched, retrospective cohort study
▪︎ Primary endpoint: cumulative event-free survival at 1 year.
▪︎azathioprine 44% 🆚️ tofacitinib 75.%
Massimo (@rainmaker1973) 's Twitter Profile Photo

Fun fact. Modern humans first appeared about 250,000 years ago, but record keeping didn't began until about 6,000 years ago. That means, about 97% of human history is lost forever. [✏️ Tim Urban]

Fun fact.

Modern humans first appeared about 250,000 years ago, but record keeping didn't began until about 6,000 years ago. 

That means, about 97% of human history is lost forever.

[✏️ <a href="/waitbutwhy/">Tim Urban</a>]
Beatriz Gros (@bealoquebea) 's Twitter Profile Photo

🔑ACG 2025 Preventive Care in IBD.Key Points: ✅ Vaccinations: - PCV20 or PCV21 instead of older schedules - Shingrix (2-dose recombinant) for all ≥50 yrs and ≥19 yrs if on immunosuppression - RSV vaccine for all ≥75 yrs & for 50–74 yrs w additional chronic conditions -

🔑ACG 2025 Preventive Care in IBD.Key Points:

✅ Vaccinations:
-  PCV20 or PCV21 instead of older schedules
- Shingrix (2-dose recombinant) for all ≥50 yrs and ≥19 yrs if on immunosuppression
- RSV vaccine for all ≥75 yrs &amp; for 50–74 yrs w additional chronic conditions
-